Citation: We. Fisher et Dh. Berger, Regulation of pancreatic cancer growth by gastrointestinal hormones: A clinically useful strategy?, MD AND SOIL, 2002, pp. 377-387
Authors:
Williams, AM
Gies, DR
Bagnuolo, WG
Berger, DH
Erling, PA
Fallon, TJ
Harvin, JA
Huang, W
Jao, WC
Josephs, TS
McFarland, JP
McSwain, MV
Riddle, RL
Wallace, DJ
Wingert, DW
Fullerton, AW
Bolton, CT
Citation: Am. Williams et al., Detection of the faint companion in the massive binary HD 199579, ASTROPHYS J, 548(1), 2001, pp. 425-428
Authors:
Albo, D
Berger, DH
Vogel, J
Tuszynski, GP
Citation: D. Albo et al., Thrombospondin-1 and transforming growth factor beta-1 upregulate plasminogen activator inhibitor type 1 in pancreatic cancer, J GASTRO S, 3(4), 1999, pp. 411-417
Authors:
Sheng, HM
Shao, JY
O'Mahony, CA
Lamps, L
Albo, D
Isakson, PC
Berger, DH
DuBois, RN
Beauchamp, RD
Citation: Hm. Sheng et al., Transformation of intestinal epithelial cells by chronic TGF-beta 1 treatment results in downregulation of the type II TGF-beta receptor and induction of cyclooxygenase-2, ONCOGENE, 18(4), 1999, pp. 855-867
Authors:
O'Mahony, CA
Beauchamp, RD
Albo, D
Tsujii, M
Sheng, HM
Shao, J
Dubois, RN
Berger, DH
Citation: Ca. O'Mahony et al., Cyclooxygenase-2 alters transforming growth factor-beta 1 response during intestinal tumorigenesis, SURGERY, 126(2), 1999, pp. 364-370
Authors:
Albo, D
Berger, DH
Rothman, VL
Tuszynski, GP
Citation: D. Albo et al., Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion, J SURG RES, 82(2), 1999, pp. 331-338
Authors:
Berger, DH
Chang, H
Wood, M
Huang, L
Heath, CW
Lehman, T
Ruggeri, BA
Citation: Dh. Berger et al., Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status, CANCER, 85(2), 1999, pp. 326-332